Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
PUT
Macy's
M
$6.26B
| $47.6M | 0.01% |
4,234,300
+512,500
| +14% | +$4.39M |
|
927
Thermo Fisher Scientific
TMO
$223B
| $47.5M | 0.01% |
102,030
+75,824
| +289% | +$35.6M |
|
928
PUT
SLB Ltd
SLB
$78.1B
| $47.5M | 0.01% |
2,176,000
-1,345,000
| -38% | -$25.4M |
|
929
Equinix
EQIX
$105B
| $47.3M | 0.01% |
66,286
+44,181
| +200% | +$32.9M |
|
930
PUT
ProShares Short VIX Short-Term Futures ETF
SVXY
$234M
| $47.3M | 0.01% |
2,284,650
+1,068,050
| +88% | +$20.7M |
|
931
PUT
iShares Semiconductor ETF
SOXX
$46.6B
| $47.3M | 0.01% |
374,400
+184,200
| +97% | +$21.1M |
|
932
Simon Property Group
SPG
$71.4B
| $47.2M | 0.01% |
553,806
-252,652
| -31% | -$19.3M |
|
933
Cooper Companies
COO
$15B
| $47.2M | 0.01% |
519,952
-46,656
| -8% | -$4M |
|
934
CALL
CSX Corp
CSX
$92.8B
| $47.2M | 0.01% |
1,560,900
+65,400
| +4% | +$1.88M |
|
935
CALL
EOG Resources
EOG
$75.1B
| $47.2M | 0.01% |
946,600
+37,700
| +4% | +$1.64M |
|
936
American Financial Group
AFG
$12B
| $47.1M | 0.01% |
537,626
+47,379
| +10% | +$3.89M |
|
937
Owens Corning
OC
$12.3B
| $47.1M | 0.01% |
621,255
-1,896,401
| -75% | -$138M |
|
938
CALL
Unity
U
$20.2B
| $47M | 0.01% |
306,400
+262,200
| +593% | +$31.9M |
|
939
Syndax Pharmaceuticals
SNDX
$1.77B
| $47M | 0.01% |
2,111,518
+1,549,104
| +275% | +$32.1M |
|
940
PUT
Microchip Technology
MCHP
$42.2B
| $46.9M | 0.01% |
679,800
-502,600
| -43% | -$31.3M |
|
941
Kraft Heinz
KHC
$30.1B
| $46.9M | 0.01% |
1,354,086
-1,235,295
| -48% | -$40.1M |
|
942
PUT
S&P Global
SPGI
$125B
| $46.7M | 0.01% |
142,200
-22,300
| -14% | -$7.52M |
|
|
HZNP
943
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $46.7M | 0.01% |
638,890
-646,067
| -50% | -$48M |
|
|
GOOS
944
Canada Goose Holdings
GOOS
$844M
| $46.7M | 0.01% |
1,569,590
+1,294,789
| +471% | +$43.2M |
|
945
CALL
Direxion Daily Financial Bull 3x ETF
FAS
$2.5B
| $46.7M | 0.01% |
768,400
+183,900
| +31% | +$8.57M |
|
|
LNW
946
DELISTED
Light & Wonder
LNW
| $46.7M | 0.01% |
1,124,822
+815,275
| +263% | +$30M |
|
947
CALL
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.5B
| $46.6M | 0.01% |
702,500
-553,400
| -44% | -$26.9M |
|
948
Masco
MAS
$14.7B
| $46.6M | 0.01% |
847,620
+736,381
| +662% | +$40.6M |
|
949
State Street Materials Select Sector SPDR ETF
XLB
$8.57B
| $46.5M | 0.01% |
1,285,606
+791,952
| +160% | +$27.1M |
|
950
CALL
iShares Expanded Tech-Software Sector ETF
IGV
$15.2B
| $46.5M | 0.01% |
656,000
+131,000
| +25% | +$8.68M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.